Top Markets
Coin of the day
Onconic Therapeutics Onconic Therapeutics

Onconic Therapeutics

476060
Rangering i aksjer #21276
Onconic Therapeutics, Inc. operates as a biopharmaceutical enterprise,... Onconic Therapeutics, Inc. operates as a biopharmaceutical enterprise, primarily dedicated to the discovery and advancement of novel therapeutic solutions. Its research and development initiatives principally focus on creating new medications for acid-related ailments and various oncological conditions. This company was established on May 7, 2020, and maintains its principal office in Seoul, South Korea.
Aksjekurs
$10.04
Sist synkronisert: 2026-08-21
Markedsverdi
$111.12M
Endring (1 dag)
-1.43%
Endring (1 år)
-40.73%
Land
KR
Handel Onconic Therapeutics (476060)

Kategori

P/B-forhold for Onconic Therapeutics (476060)
P/B-forhold per 2026 TTM: 0
Ifølge Onconic Therapeutics sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Onconic Therapeutics fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
6.3419 -
US
6.2413 -
NL
3.7087 -
US
2.5054 -
AU
- -
CH